Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

New Zealand's Chris Wood scores a hat trick of headed goals as they beat Fiji 7-0 to reach the Oceania qualifying final for ...